New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 13, 2012
10:24 EDTFINL, VMW, NKE, HBI, DOV, UA, MAKO, FL, DSCI, NTRI, SNSS, HLSSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Derma Sciences (DSCI) initiated with an Overweight at Piper Jaffray... Dover (DOV) initiated with an Outperform at BMO Capital... Finish Line (FINL) initiated with a Buy at Janney Capital... Foot Locker (FL) initiated with a Buy at Janney Capital... Hanesbrands (HBI) initiated with a Buy at Janney Capital... Home Loan Servicing (HLSS) initiated with a Neutral at Sterne Agee... Mako Surgical (MAKO) initiated with a Perform at Oppenheimer... Nike (NKE) initiated with a Buy at Janney Capital... Sunesis Pharmaceuticals (SNSS) initiated with a Buy at Cantor... Under Armour (UA) initiated with a Neutral at Janney Capital... VMware (VMW) initiated with an Overweight at Piper Jaffray... NutriSystem (NTRI) initiated with a Buy at Sidoti.
News For DSCI;DOV;FINL;FL;HBI;HLSS;MAKO;NKE;SNSS;UA;VMW;NTRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
December 12, 2014
06:34 EDTVMWVMware resumed with an Underweight from Overweight at Piper Jaffray
Subscribe for More Information
December 11, 2014
07:58 EDTVMWVMware pullback creates attractive entry point, says RBC Capital
After meeting with VMware's management, RBC Capital continues to believe that the company has significant cross selling opportunities and can benefit from a $60B data center total available market. The firm believes that several of the company's markets could reach a positive turning point in 2015. RBC keeps an Outperform rating on the shares.
06:33 EDTNKENike CIO Anthony Watson leaves company after 10 months, Business Insider reports
Subscribe for More Information
December 10, 2014
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTSNSSOn The Fly: Pre-market Movers
Subscribe for More Information
09:15 EDTNKENike price target raised to $105 from $100 at Credit Suisse
Subscribe for More Information
07:25 EDTNKENike sues employees who left for Adidas for stealing trade secrets, ESPN reports
Subscribe for More Information
06:40 EDTSNSSSunesis upgraded to Buy from Hold at Cantor
Subscribe for More Information
December 9, 2014
17:03 EDTNKENike appoints Tom Peddie as VP and GM of the Emerging Markets
Subscribe for More Information
10:23 EDTDOVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:19 EDTDOVDover downgraded to Sell from Hold at Deutsche Bank
Subscribe for More Information
December 8, 2014
13:34 EDTSNSSSunesis announces positive results from ongoing trial of Vosaroxin
Subscribe for More Information
12:40 EDTSNSSOn The Fly: Midday Wrap
Subscribe for More Information
10:00 EDTNKEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:29 EDTSNSSSunesis risk/reward attractive, says RBC Capital
RBC Capital believes that the EU could approve Sunesis' vosaroxin drug. The firm says that an EU approval would lift the stock by about 35%, and ir keeps a $3 price target and Sector Perform rating on the shares.
08:49 EDTDOVDover cuts FY14 adjusted EPS $4.55-$4.62 from $4.750$4.80, consensus $4.77
Subscribe for More Information
08:48 EDTDOVDover sees FY15 EPS $5.05-$5.30, consensus $5.21
Subscribe for More Information
06:38 EDTNKENike downgraded to Market Perform from Outperform at Telsey Advisory
Subscribe for More Information
06:08 EDTDOVDover to host investor meeting
Subscribe for More Information
05:51 EDTSNSSSunesis to host conference call
Conference call to discuss results from the Phase 3 VALOR trial of vosaroxin and cytarabine will be held on December 9 at 1:30 pm. Webcast Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use